Identification of mcr-13 in the Endangered Lynx pardinus, and mcr-1 in Sus scrofa, Expands the Diversity of Plasmid-Mediated Colistin Resistance Determinants of Escherichia coli from Wildlife

Résumé fourni par la source

Background: Plasmid-mediated colistin resistance threatens the effectiveness of one of the last-line antibiotics for treating multidrug-resistant Gram-negative infections. Although wildlife is increasingly recognized as a reservoir of mobile antimicrobial resistance genes, its role in the emergence and dissemination of novel plasmid-mediated colistin resistance (mcr) genes remains poorly understood. Objectives: This study aimed to characterize two distinct mcr-carrying E. coli isolates identified in Spanish wildlife. Methods: Among 807 faecal samples from healthy wild animals screened, two mcr-positive E. coli isolates were identified. Genomic characterization included whole-genome sequencing, plasmid analysis, and functional assays, followed by heterologous expression and lipid A characterization by Ultra-High-Performance Liquid Chromatography coupled with High-Resolution Mass Spectrometry (UHPLC-HRMS). Results: Analysis of the two mcr-positive E. coli isolates revealed the first mcr-1-positive isolate from a wild boar (Sus scrofa) in Extremadura, Spain, carrying mcr-1 on a 33.3-kb conjugative IncX4 plasmid, while the isolate recovered from an Iberian lynx harbored mcr-13, a novel plasmid-borne mcr-like gene encoding a putative phosphoethanolamine (pEtN) transferase on a 163-kb non-conjugative plasmid. MCR-13 showed 82% amino acid identity with MCR-10, increased colistin MIC two-fold in a susceptible E. coli host, and mediated phosphoethanolamine modification of lipid A, although to a lower extent than MCR-1. Conclusions: The co-occurrence of established (mcr-1) and a novel mcr-like gene mcr-13, further supports the role of wildlife as a potential reservoir of emerging resistance genes and highlights the value of including wildlife in One Health surveillance programs.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.